SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 14, 2000
OSTEOTECH, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-19278 13-3357370
(State or other jurisdiction (Commission file (IRS Identification
of incorporation) Number) No.)
51 James Way, Eatontown, New Jersey 07724
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (732) 542-2800
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
On February 14, 2000, Osteotech, Inc. reported that it has entered into an
agreement with Spinal Concepts, Inc. to co-promote Osteotech's Grafton(R)
Demineralized Bone Matrix (DBM) with Spinal Concepts' InFix(R) Interbody Fusion
System for the treatment of degenerative disc disease of the lumbar spine. This
agreement provides for the combination of Grafton(R) DBM, the most widely used
off-the-shelf bone grafting material in the world, with the InFix(R) Interbody
Fusion System, currently undergoing IDE clinical trials at numerous centers
around the US. As a first step, the companies will work together to help Spinal
Concepts gain regulatory approval through completion of a prospective,
randomized clinical trial of patients followed for a period of two years.
Osteotech will help support the study through a series of milestone payments.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: February 17, 2000
OSTEOTECH, INC.
--------------------------
(Registrant)
By: /s/ Michael J. Jeffries
----------------------------
MICHAEL J. JEFFRIES
Executive Vice President,
Chief Financial Officer
and Secretary
